Iron oxide nanoparticles for sustained delivery of anticancer agents.

By T. Jain, M. Morales, S. Sahoo, D. Leslie-Pelecky, V. Labhasetwar. Molecular Pharmaceutics, 2005

866 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. (2011, neutral): “Oleic acid–Pluronic Aqueous media Doxorubicin In vitro [252]”
Application in the Ethanol Fermentation of Immobilized Yeast Cells in Matrix of Alginate/Magnetic Nanoparticles, on Chitosan-Magnetite Microparticles and Cellulose-coated Magnetic Nanoparticles (2011, background): “Fe(II) and Fe(III) with molar ratio of 1:2 in alkaline medium, [34]-[35]-[36]) to 3% (w/v) final concentration of sodium alginate, final cell content 100-250 mg/mL gel and 5-20% (w/v) final nanoparticles content.”
Zinc Oxide Nanoparticles for Selective Destruction of Tumor Cells and Potential for Drug Delivery Applications (2010, background): “Iron oxide magnetic nanoparticles have been used successfully for loading high doses of water-insoluble anticancer agents to mediate dose-dependent antiproliferative effects in breast and prostate cancer lines [101].”